Response to Radiotherapy for Advanced Squamous Cell Carcinoma and Adenocarcinoma of the Cervix at Ulin Regional General Hospital, Banjarmasin, Indonesia
Research
DOI:
https://doi.org/10.55175/cdk.v52i9.1355Keywords:
Adenocarcinoma, cervical cancer, squamous cell carcinoma, radiotherapyAbstract
Introduction: Cervical carcinoma (cancer) is a malignancy in the cervix and is one of the most common cancers in women. Data released by GLOBOCAN in 2022 showed that cervical cancer ranks eighth globally. The main treatment for advanced cervical cancer is radiotherapy. The aim of this study is to compare the radiotherapy response in squamous cell carcinoma cervical cancer with the response in adenocarcinoma cervical cancer at Ulin Regional Hospital, Banjarmasin, Indonesia. Methods: This cross-sectional research used an analytical observational design. Total sample during the research period from January 2021 to December 2022. Results: Total of 128 cervical cancer patients consisting of 91 squamous cell carcinomas and 37 adenocarcinomas. Chi-square analysis found a significant association between histopathology and response to therapy; squamous cell carcinoma histopathology was more radiosensitive than adenocarcinoma. Conclusion: Histopathological type is the only characteristic significantly associated with radiation response, whereas age, stage, and tumor size are not significantly associated with radiation response.
Downloads
References
Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer: the Lancet Commision Report. Lancet [Internet]. 2019;393:169-82. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)32470-X/abstract.
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. ACS J. 2024;74(3):205-313. doi: 10.3322/caac.21834.
Latifah HJ, Nurachmah, Elly, Hiryadi. Faktor yang berkontribusi terhadap motivasi menjalani pemeriksaan Pap smear pasien kanker serviks di poli Kandungan. Banjarmasin: J Keperawatan Suaka Insan. 2020;5:90-9. doi: 10.51143/jksi.v5i1.192.
Bohm ELJF, Hendy J, Hill R, Le Heron J, Mishra K, Trott K, et al. Radiation biology: a handbook for teachers and students. Training course series. Vienna: International Atomic Energy Agency; 2017.
Andrijono, Purwoto G, Sekarutami SM, Handjari DR, Primariadewi, Nuhonni SA, et al. Kemenkes RI. Pedoman nasional pelayanan kedokteran kanker serviks. Jakarta: Komite Penanggulangan Kanker Nasional; 2019.
Gunderson LL, Joel ET. Clinical radiation oncology. 3rd ed. Philadelphia: Elsevier Saunders; 2017 .p. 8-29.
Hopkins MP, Morley GW. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol. 1991;77(6):912–7. PMID: 2030867.
Seiwert TY, Salama JK, Vokes EE. The concurrent chemoradiation paradigm--general principles. Nature Clin Pract Oncol. 2017;4(2):86-100. doi: 10.1038/ncponc0714.
Nagy VM, Buiga R, Brie I, Nicolae T. Expression of VEGF, VEGFR, EGFR, COX-2 and MVD in cervical carcinoma, in relation with the response to radio-chemotherapy. Rom J Morphol Embryol. 2011;52(1):53-9. PMID: 21424032.
Chen F, Chen L, Zhang Y, Shi L, Xu H, Song T. Survival comparison between squamous cell carcinoma and adenocarcinoma for radiotherapy-treated patients with stage IIB-Iva cervical cancer. Front Oncol. 2022 Jul 22:12:895122. doi: 10.3389/fonc.2022.895122.
Espenel S, Garcia MA, Trone JC, Guillaume E, Harris A, Rehailia-Blanchard A, et al. Correction to: from IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience. Radiat Oncol. 2018 Mar 23;13(1):50. doi: 10.1186/s13014-018-0999-9.
Isla-Ortiz D, Palomares-Castillo E, Mille-Loera JE, Ramirez-Calderon N, Mohar-Betancourt A, Meneses-Garcia AA, et al. Cervical cancer in young women: do they have a worse prognosis? a retrospective cohort analysis in a population of Mexico. Oncologist 2020 Sep;25(9):e1363-e1371. doi: 10.1634/theoncologist.2019-0902.
Lee KC, Kim HJ, Sung K, Choi YE, Lee SH, Lim S, et al. The predictive value of tumor size, volume, and markers during radiation therapy in patients with cervical cancer. Int J Gynecol Cancer. 2017 Jan;27(1):123-130. doi: 10.1097/IGC.0000000000000837.
Xiu YT, Meng FX, Wang Z, Zhao KK, Wang YL, Chen ZS, et al. Prognostic factors for IB2-IIIB cervical cancer patients treated by radiation therapy with high-dose-rate brachytherapy in a single-institution study. J Contemp Brachytherapy. 2022 Aug;14(4):332-340. doi: 10.5114/jcb.2022.118674.
Zhang Y, Shu P, Wang X, Ouyang G, Zhou J, Zhao Y, et al. Comparison of survival between different histological subtypes in cervical cancer patients: A retrospective and propensity score-matched analysis. Journal of Cancer 2024;15(19):6326-35. doi: 10.7150/jca.100653.
Katanyoo K, Sanguanrungsirikul S, Manusirivithaya S. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer. Gynecol Oncol. 2012;125(2):292–6. doi: 10.1016/j.ygyno.2012.01.034.
Pringgowibowo J, Suardi D, Anwar R. Cervical cancer radiotherapy response in dr. Hasan Sadikin General Center Hospital. Indon J Obstetr Gynecol Sci. 2022;5(1):54–62. doi: 10.24198/obgynia.v5i1.340.
Tokumo K, Kodama J, Seki N, Nakanishi Y, Miyagi Y, Kamimura S, et al. Different angiogenic pathways in human cervical cancers. Gynecol Oncol. 2017; 68(1):38-44. doi: 10.1006/gyno.1997.4876.
Saijo Y, Furumoto H, Yoshida K, Nishimura M, Irahara M. Clinical significance of vascular endothelial growth factor expression and microvessel density in invasive cervical cancer. J Medical Investig. 2015;(62):154-60. doi: 10.2152/jmi.62.154.
Hu X, Liu H, Ye M, Zhu X. Prognostic value of microvessel density in cervical cancer. Cancer Cell Int. 2018;18:152. doi: 10.1186/s12935-018-0647-3.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Natasha Bharat Sindunata, Eka Indah Pratiwi, Arlavinda Asmara Lubis
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
